SIGNATUREFD, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 166 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2018. The put-call ratio across all filers is 9.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2024$31,359
-9.1%
763
+3.2%
0.00%0.0%
Q1 2024$34,504
+6.6%
739
+9.2%
0.00%0.0%
Q4 2023$32,374
-1.0%
677
-26.2%
0.00%0.0%
Q3 2023$32,691
-30.6%
917
-10.2%
0.00%0.0%
Q2 2023$47,099
+64.0%
1,021
+42.6%
0.00%0.0%
Q1 2023$28,712
-57.6%
716
-51.0%
0.00%
-50.0%
Q4 2022$67,734
+170.9%
1,462
+143.7%
0.00%
+100.0%
Q3 2022$25,000
+78.6%
600
+151.0%
0.00%
Q2 2022$14,000
+40.0%
239
+69.5%
0.00%
Q1 2022$10,000
+25.0%
141
+50.0%
0.00%
Q4 2021$8,000
+300.0%
94
+248.1%
0.00%
Q3 2021$2,000
+100.0%
27
+350.0%
0.00%
Q2 2021$1,000
-50.0%
6
-64.7%
0.00%
Q1 2021$2,000
-33.3%
17
-22.7%
0.00%
Q4 2020$3,00022
+266.7%
0.00%
Q3 2020$06
+500.0%
0.00%
Q3 2018$010.0%0.00%
Q2 2018$010.0%0.00%
Q1 2018$010.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2018
NameSharesValueWeighting ↓
First Light Asset Management, LLC 217,459$24,760,0001.64%
Motley Fool Asset Management LLC 152,326$17,344,0001.25%
Rock Springs Capital Management LP 450,000$51,237,0001.12%
AtonRa Partners 21,017$2,393,0001.07%
SECTORAL ASSET MANAGEMENT INC 112,200$12,775,0000.97%
EMERALD ADVISERS, LLC 228,368$26,002,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 239,023$27,215,0000.90%
FEDERATED HERMES, INC. 3,912,408$445,467,0000.86%
HealthCor Management, L.P. 207,610$23,638,0000.84%
Atika Capital Management LLC 66,000$7,515,0000.65%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders